Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation

Platelets

Volumn 21, Issue 5, 2010, Pages 348-359

  Esch, Jan Schulte Am ^a   Jurk, Kerstin ^b   Knoefel, Wolfram T ^a   Roeder, Gesine ^a   Voss, Holger ^a   Tustas, Roy Y ^a   Schmelzle, M ^a   Krieg, Andreas ^a   Eisenberger, Claus F ^a   Topp, Stefan ^a   Rogiers, Xavier ^d   Fischer, Lutz ^c   Aken, Hugo Van ^b   Kehrel, Beate E ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Haemostasis; Inflammation; Microparticles; Platelets; Tissue factor; Transplantation

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; CD40 LIGAND; CREATININE; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; PADGEM PROTEIN; PROTHROMBIN; SODIUM; TACROLIMUS; THROMBOPLASTIN; THROMBOSPONDIN 1; UREA;

ADULT; ARTICLE; BLEEDING; BLOOD SAMPLING; CELL ACTIVATION; CLINICAL ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; FEMALE; FLOW CYTOMETRY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOSTASIS; HEPATITIS; HUMAN; IN VIVO STUDY; LEUKOCYTE; LEUKOCYTE COUNT; LIVER; LIVER CELL DAMAGE; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER PERFUSION; LIVER TRANSPLANTATION; MALE; MONOCYTE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; REPERFUSION; REPERFUSION INJURY; RISK; SODIUM BLOOD LEVEL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; THROMBOGENESIS; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; INFLAMMATION; LIVER DISEASE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; VASCULARIZATION;

ADULT; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MONOCYTES; PLATELET ACTIVATION; PROSPECTIVE STUDIES; REPERFUSION INJURY; THROMBOPLASTIN;

EID: 77954778345     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537101003739897     Document Type: Article

References (42)

1. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993;55:807-813. (Pubitemid 23122053)
2. Snover DC, Sibley RK, Freese DK, Sharp HL, Bloomer JR, Najarian JS, Ascher NL. Orthotopic liver transplantation: A pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology 1984;4:1212-1222.
3. von Hundelshausen P, Weber C. Platelets as immune cells: Bridging inflammation and cardiovascular disease. Circ Res 2007;100:27-40.
4. Kehrel BE, Jurk K. Platelets at the interface between hemostasis and innate immunity. Transfus Med Hemother 2004;31:379-386.
5. Schulte am Esch J, Tustas RY, Robson SC, Hosch SB, Akyildiz A, Broring DC, Fischer L, Knoefel WT, Rogiers X. Recipient levels and function of von Willebrand factor prior to liver transplantation and its consumption in the course of grafting correlate with hepatocellular damage and outcome. Transpl Int 2005;18:1258-1265.
6. Sindram D, Porte RJ, Hoffman MR, Bentley RC, Clavien PA. Platelets induce sinusoidal endothelial cell apoptosis upon reperfusion of the cold ischemic rat liver. Gastroenterology 2000;118:183-191.
7. Cywes R, Packham MA, Tietze L, Sanabria JR, Harvey PR, Phillips MJ, Strasberg SM. Role of platelets in hepatic allograft preservation injury in the rat. Hepatology 1993;18:635-647.
8. Cywes R, Harvey PR, Packham MA, Cameron R, Strasberg SM. The influence of prostaglandin E1 on platelet adherence and injury in preserved rat liver allografts. Liver Transpl Surg 1996;2:23-36.
9. Pesonen EJ, Hockerstedt K, Makisalo H, Vuorte J, Jansson SE, Orpana A, Karonen SL, Repo H. Transhepatic neutrophil and monocyte activation during clinical liver transplantation. Transplantation 2000;69:1458-1464.
10. Kiuchi T, Oldhafer KJ, Schlitt HJ, Nashan B, Deiwick A, Wonigeit K, Ringe B, Tanaka K, Yamaoka Y, Pichlmayr R. Background and prognostic implications of perireperfusion tissue injuries in human liver transplants: A panel histochemical study. Transplantation 1998;66:737-747.
11. Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000;20: 2322-2328.
12. Ushigome H, Sano H, Okamoto M, Kadotani Y, Nakamura K, Akioka K, Yoshimura R, Ohmori Y, Yoshimura N. The role of tissue factor in renal ischemic reperfusion injury of the rat. J Surg Res 2002;102:102-109.
13. Monroe DM, Hoffman M. What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 2006;26:41-48.
14. Mueller AR, Platz KP, Haak M, Undi H, Müller C, Köttgen E, Weidemann H, Neuhaus P. The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation 1996;62:1118-1126.
15. Berberat PO, Friess H, Schmied B, Kremer M, Gragert S, Flechtenmacher C, Schemmer P, Schmidt J, Kraus T, Uhl W, et al. Differentially expressed genes in postperfusion biopsies predict early graft dysfunction after liver transplantation. Transplantation 2006;82:699-704.
16. Kehrel B, Wierwille S, Clemetson KJ, Anders O, Steiner M, Knight CG, Farndale RW, Okuma M, Barnes MJ. Glycoprotein VI is a major collagen receptor for platelet activation: It recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 1998;91:491-499.
17. Rennemeier C, Hammerschmidt S, Niemann S, Inamura S, Zahringer U, Kehrel BE. Thrombospondin-1 promotes cellular adherence of gram-positive pathogens via recognition of peptidoglycan. FASEB J 2007;21:3118-3132. (Pubitemid 47565532)
18. Xia Z, Wong T, Liu Q, Kasirer-Friede A, Brown E, Frojmovic MM. Optimally functional fluorescein isothiocyanate- labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation. Br J Haematol 1996;93:204-214.
19. Jurk K, Jahn UR, Van Aken H, Schriek C, Droste DW, Ritter MA, Ringelstein EB, Kehrel BE. Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1). Thromb Haemost 2004;91:334-344.
20. Liu W, Schob O, Pugmire JE, Jackson D, Zucker KA, Fry DE, Glew RH. Glycohydrolases as markers of hepatic ischemia-reperfusion injury and recovery. Hepatology 1996;24:157-162.
21. McCaughan GW, Herkes R, Powers B, Rickard K, Gallagher ND, Thompson JF, Sheil AG. Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol 1992;16:16-22.
22. Pereboom ITA, Adelmeijer J, van Leeuwen Y, Hendriks HG, Porte RJ, Lisman T. No evidence for systemic platelet activation during or after orthopic liver transplantation. Liver Transpl 2009;15:956-962.
23. Khandoga A, Biberthaler P, Enders G, Axmann S, Hutter J, Messmer K, Krombach F. Platelet adhesion mediated by fibrinogen-intercelllular adhesion molecule-1 binding induces tissue injury in the postischemic liver in vivo. Transplantation 2002;74:681-688.
24. Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien PA. P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999;29:1494-1502.
25. Borghi-Scoazec G, Scoazec JY, Durand F, Bernuau J, Belghiti J, Feldmann G, Henin D, Degott C. Apoptosis after ischemiareperfusion in human liver allografts. Liver Transpl Surg 1997;3:407-415.
26. Singbartl K, Forlow SB, Ley K. Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J 2001;15:2337-2344.
27. Ishikawa M, Vowinkel T, Stokes KY, Arumugam TV, Yilmaz G, Nanda A, Granger DN. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation 2005;111:1690-1696.
28. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-594.
29. Jurk K, Clemetson KJ, de Groot PG, Brodde MF, Steiner M, Savion N, Varon D, Sixma JJ, Van Aken H, Kehrel BE. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): An alternative/backup mechanism to von Willebrand factor. FASEB J 2003;17:1490-1492.
30. Thakar CV, Zahedi K, Revelo MP, Wang Z, Burnham CE, Barone S, Bevans S, Lentsch AB, Rabb H, Soleimani M. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest 2005;115:3451-3459.
31. Matsuyama M, Yoshimura R, Akioka K, Okamoto M, Ushigome H, Kadotani Y, Nakatani T, Yoshimura N. Tissue factor antisense oligonucleotides prevent renal ischemia- reperfusion injury. Transplantation 2003;76:786-791. (Pubitemid 37140220)
32. Monroe DM, Hoffman M, Roberts HR. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis 1996;7:459-464.
33. Scholz T, Temmler U, Krause S, Heptinstall S, Losche W. Transfer of tissue factor from platelets to monocytes: Role of platelet-derived microvesicles and CD62P. Thromb Haemost 2002;88:1033-1038.
34. Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998;102:136-144.
35. Dörmann D, Clemetson KJ, Kehrel BE. The GPIb thrombinbinding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000;96:2469-2478.
36. Kroemer A, Xiao X, Degauque N, Edtinger K, Wei H, Demirci G, Li XC. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008;180:7818-7826.
37. Perrella O, Sbreglia C, Arenga G, Perrella A, Ferrara A, D'Antonio A, Di Costanzo G, Atripaldi L, Alone C, Sciano D, et al. Acute rejection after liver transplantation: Is there a specific immunological pattern? Transplant Proc 2006;38:3594-3596.
38. Pignatelli P, Sanguigni V, Lenti L, Loffredo L, Carnevale R, Sorge R, Violi F. Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: Effect of atorvastatin. J Thromb Haemost 2007;5:1170-1178.
39. Rao AK, Vaidyula VR, Bagga S, Jalagadugula G, Gaughan J, Wilhite DB, Comerota AJ. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease. Thromb Haemost 2006;96:738-743.
40. Pereboom IT, Lisman T, Porte RJ. Platelets in liver transplantation: Friend or foe? Liver Transpl 2008; 14:923-931.
41. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA. Platelet-derived serotonin mediates liver regeneration. Science 2006;312:104-107.
42. Nocito A, Georgiev P, Dahm F, Jochum W, Bader M, Graf R, Clavien PA. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology 2007;45:369-376.